BUSINESS: The Global Market For Pharmaceutical Contract Development And Manufacture Is Expected To Grow At 7.3% CAGR

dWeb.News Article from Daniel Webster dWeb.News

dWeb.News Article from Daniel Webster dWeb.News

by Daniel Webster, dWeb.News Publisher

New York, Oct. 13, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Pharmaceutical Contract Development and Manufacturing Market, End User -Global Forecast to 2026” – https://www.reportlinker.com/p05803740/?utm_source=GNW
The increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements in cell and gene therapies are also expected to offer market growth opportunities in the coming years.
The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market, byend user, during the forecast period
The pharmaceutical contract development and manufacturing market is segmented intobig pharmaceutical companies, small & medium-sized pharmaceutical companies, generic pharmaceutical companies, and other end users.The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market in 2021. This segment’s rapid growth is due to the growing number of new pharmaceutical companies that do not have the resources to develop and manufacture complex formulations or drug products.

Biologics manufacturing services segment accounted for the highest CAGR
Based on service, the pharmaceutical contract development and manufacturing market is segmented into pharmaceutical manufacturing, biologics manufacturing, and drug development services.In 2021, the biologics manufacturing services segment accounted for the highest growth rate. The main driver of the segment’s growth is the increasing demand for biosimilars and vaccines.

Asia Pacific: The fastest-growing countryin thepharmaceutical contract development and manufacturing market
Thepharmaceutical contract development and manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.Asia Pacific is projected to register the highest CAGR during the forecast period. This growth can be attributed mainly to the growth in the manufacturing industry, favorable government regulations and increased strategic expansions by leading companies.

The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 80%and Demand Side 20%
By Designation: C-level – 25%, D-level – 20%, and Others – 55%
By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

Lists of Companies Profiled in the Report:
Thermo Fisher Scientific Inc. (US)
Catalent, Inc. (US)
Lonza Group Ltd. (Switzerland)
Recipharm AB (Sweden)
Siegfried Holding AG (Switzerland)
WuXiAppTec (China)
Samsung Biologics (South Korea)
Boehringer Ingelheim International GmbH (Germany)
Piramal Pharma Solutions (India)
Vetter Pharma International GmbH (Germany)
FAMAR Health Care Services (France)
AbbVie Inc. (US)
Aenova Group (Germany)
Almac Group (UK)
Evonik Industries AG (Germany)
Cambrex Corporation (US)
CordenPharma International (Germany)
Albany Molecular Research Inc. (AMRI) (US)
FUJIFILM Corporation (Japan)
BioVectra (Canada)

Research Coverage:
This report provides a detailed picture of thepharmaceutical contract development and manufacturing market.It aims at estimating the size and future growth potential of the market across different segments,such as the service, end user, and region. The report includes a detailed competitive analysis of the key market players as well as their company profiles, recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical contract development and manufacturing marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will help stakeholders understand the market and give them information about the key market drivers and trends.
Read the full report: https://www.reportlinker.com/p05803740/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker organizes and finds the most recent industry data, so you can get all your market research in one place.

__________________________

For more dWeb.News Business News: https://dweb.news/news-sections/business-news/

The post BUSINESS: The Global Market For Pharmaceutical Contract Development And Manufacture Is Expected To Grow At 7.3% CAGR appeared first on dWeb.News dWeb.News from Daniel Webster Publisher dWeb.News – dWeb Local Tech News and Business News

The post BUSINESS: The Global Market For Pharmaceutical Contract Development And Manufacture Is Expected To Grow At 7.3% CAGR appeared first on dWeb.News dWeb.News from Daniel Webster Publisher dWeb.News – dWeb Local Tech News and Business News

dWeb.NewsRead More

Similar Posts